Smoking cessation in pregnancy

a continuing challenge in the United States

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Despite significant population level declines, smoking during pregnancy remains a major public health issue in the United States (US). Approximately 360,000–500,000 smoke-exposed infants are born yearly, and prenatal smoking remains a leading modifiable cause of poor birth outcomes (e.g. birth < 37 gestational weeks, low birth weight, perinatal mortality). Women who smoke during pregnancy are more likely to be younger and from disadvantaged socioeconomic and racial and ethnic groups, with some US geographic regions reporting increased prenatal smoking rates since 2000. Such disparities in maternal prenatal smoking suggests some pregnant women face unique barriers to cessation. This paper reviews the current state and future direction of smoking cessation in pregnancy in the US. We briefly discuss the etiology of smoking addiction among women, the pathophysiology and effects of tobacco smoke exposure on pregnant women and their offspring, and the emerging issue of electronic nicotine delivery systems. Current population-based and individual smoking cessation interventions are reviewed in the context of pregnancy and barriers to cessation among US women. Finally, we consider interventions that are on the horizon and areas in need of further investigation.

Original languageEnglish (US)
JournalTherapeutic Advances in Drug Safety
DOIs
StateAccepted/In press - May 1 2018

Fingerprint

Smoking Cessation
Smoking
Pregnancy
Smoke
Pregnant Women
Parturition
Perinatal Mortality
Low Birth Weight Infant
Vulnerable Populations
Nicotine
Ethnic Groups
Population
Tobacco
Public Health
Mothers

Keywords

  • Cigarettes
  • Electronic Nicotine Delivery System
  • Narrative Review
  • Nicotine
  • Smoking Cessation
  • Smoking in Pregnancy

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

@article{55287502bd134fb799f25fb1285144c6,
title = "Smoking cessation in pregnancy: a continuing challenge in the United States",
abstract = "Despite significant population level declines, smoking during pregnancy remains a major public health issue in the United States (US). Approximately 360,000–500,000 smoke-exposed infants are born yearly, and prenatal smoking remains a leading modifiable cause of poor birth outcomes (e.g. birth < 37 gestational weeks, low birth weight, perinatal mortality). Women who smoke during pregnancy are more likely to be younger and from disadvantaged socioeconomic and racial and ethnic groups, with some US geographic regions reporting increased prenatal smoking rates since 2000. Such disparities in maternal prenatal smoking suggests some pregnant women face unique barriers to cessation. This paper reviews the current state and future direction of smoking cessation in pregnancy in the US. We briefly discuss the etiology of smoking addiction among women, the pathophysiology and effects of tobacco smoke exposure on pregnant women and their offspring, and the emerging issue of electronic nicotine delivery systems. Current population-based and individual smoking cessation interventions are reviewed in the context of pregnancy and barriers to cessation among US women. Finally, we consider interventions that are on the horizon and areas in need of further investigation.",
keywords = "Cigarettes, Electronic Nicotine Delivery System, Narrative Review, Nicotine, Smoking Cessation, Smoking in Pregnancy",
author = "Ashley Scherman and Jorge Tolosa and McEvoy, {Cynthia (Cindy)}",
year = "2018",
month = "5",
day = "1",
doi = "10.1177/2042098618775366",
language = "English (US)",
journal = "Therapeutic Advances in Drug Safety",
issn = "2042-0986",
publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Smoking cessation in pregnancy

T2 - a continuing challenge in the United States

AU - Scherman, Ashley

AU - Tolosa, Jorge

AU - McEvoy, Cynthia (Cindy)

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Despite significant population level declines, smoking during pregnancy remains a major public health issue in the United States (US). Approximately 360,000–500,000 smoke-exposed infants are born yearly, and prenatal smoking remains a leading modifiable cause of poor birth outcomes (e.g. birth < 37 gestational weeks, low birth weight, perinatal mortality). Women who smoke during pregnancy are more likely to be younger and from disadvantaged socioeconomic and racial and ethnic groups, with some US geographic regions reporting increased prenatal smoking rates since 2000. Such disparities in maternal prenatal smoking suggests some pregnant women face unique barriers to cessation. This paper reviews the current state and future direction of smoking cessation in pregnancy in the US. We briefly discuss the etiology of smoking addiction among women, the pathophysiology and effects of tobacco smoke exposure on pregnant women and their offspring, and the emerging issue of electronic nicotine delivery systems. Current population-based and individual smoking cessation interventions are reviewed in the context of pregnancy and barriers to cessation among US women. Finally, we consider interventions that are on the horizon and areas in need of further investigation.

AB - Despite significant population level declines, smoking during pregnancy remains a major public health issue in the United States (US). Approximately 360,000–500,000 smoke-exposed infants are born yearly, and prenatal smoking remains a leading modifiable cause of poor birth outcomes (e.g. birth < 37 gestational weeks, low birth weight, perinatal mortality). Women who smoke during pregnancy are more likely to be younger and from disadvantaged socioeconomic and racial and ethnic groups, with some US geographic regions reporting increased prenatal smoking rates since 2000. Such disparities in maternal prenatal smoking suggests some pregnant women face unique barriers to cessation. This paper reviews the current state and future direction of smoking cessation in pregnancy in the US. We briefly discuss the etiology of smoking addiction among women, the pathophysiology and effects of tobacco smoke exposure on pregnant women and their offspring, and the emerging issue of electronic nicotine delivery systems. Current population-based and individual smoking cessation interventions are reviewed in the context of pregnancy and barriers to cessation among US women. Finally, we consider interventions that are on the horizon and areas in need of further investigation.

KW - Cigarettes

KW - Electronic Nicotine Delivery System

KW - Narrative Review

KW - Nicotine

KW - Smoking Cessation

KW - Smoking in Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85047821670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047821670&partnerID=8YFLogxK

U2 - 10.1177/2042098618775366

DO - 10.1177/2042098618775366

M3 - Article

JO - Therapeutic Advances in Drug Safety

JF - Therapeutic Advances in Drug Safety

SN - 2042-0986

ER -